Skip to main content
Equibles
QNRX logo

QNRX · Quoin Pharmaceuticals Ltd. · Webcasts, Transcripts & Audio

Track QNRX — free

Use QNRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research QNRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.05 +0.04 (+1.00%) At close · Oct 27 Q4 2023 earnings call transcript
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Based upon the Company's current business plans and cash, cash equivalents, and investments on hand, management has concluded that there is substantial doubt about the Company's ability to continue as a going concern for a period of at least one year from the date of the filing of this Quarterly Report on Form 10-Q.”
View the 10-Q filed Aug 14, 2026
Market Cap
$19.26M
Shares
4.80M
Volume · Oct 27 1522 Avg daily vol (3M) 536.56K

Quoin Pharmaceuticals Ltd. Webcasts

Earnings calls, investor updates, investor days and conferences for Quoin Pharmaceuticals Ltd. (QNRX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Key facts CIK 1671502 CUSIP 74907L409 13F (30d) 3 filings 3 filers Visit website Investor relations